Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy Subjects
Clinical trial NCT04498741 · COMPLETED
Trial details
- NCT number
- NCT04498741
- Sponsor
- Enanta Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-08
- Primary completion
- 2021-05-27
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.